FONAR Corporation

Equities

FONR

US3444374058

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-06 pm EST			5-day change	1st Jan Change
18.49 ^USD	-0.43%		-0.59%	-0.38%

Feb. 13	FONAR Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2025	CI
Dec. 30	Fonar to Be Taken Private by CEO Timothy Damadian-led Investors in All-Cash Deal	MT

FONAR Corporation Reports Earnings Results for the First Quarter Ended September 30, 2025

Published on 11/10/2025 at 12:57 pm EST

S&P Capital IQ

FONAR CORPORATION

-0.43%

FONAR Corporation reported earnings results for the first quarter ended September 30, 2025. For the first quarter, the company reported revenue was USD 26.04 million compared to USD 24.96 million a year ago. Net income was USD 2.26 million compared to USD 3.14 million a year ago.

Latest news about FONAR Corporation

Feb. 13	FONAR Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2025	CI
Dec. 30	Fonar to Be Taken Private by CEO Timothy Damadian-led Investors in All-Cash Deal	MT
Dec. 30	Top Premarket Gainers	MT
Dec. 29	Fonar Corp signs definitive agreement for "take private" sale to acquisition group led by CEO	RE
Nov. 10	Tranche Update on FONAR Corporation's Equity Buyback Plan announced on September 29, 2022.	CI
Nov. 10	FONAR Corporation Reports Earnings Results for the First Quarter Ended September 30, 2025	CI
Nov. 10	Fonar Q1 profit falls on higher expenses	RE
25-09-12	Tranche Update on FONAR Corporation's Equity Buyback Plan announced on September 29, 2022.	CI
25-09-12	FONAR Corporation Reports Earnings Results for the Full Year Ended June 30, 2025	CI
25-07-09	FONAR Reports Receiving Preliminary Acquisition Proposal From Consortium Led by Founder's Son	MT
25-07-08	Timothy Raymond Damadian along with management team, board of directors of FONAR Corporation and third parties entered into an agreement and plan of merger to acquire remaining 94.9% stake in FONAR Corporation.	CI
25-07-02	FONAR Corporation Appoints Robert M. Carrino as an Independent Director	CI
25-06-23	FONAR Corporation Announces Intention of Claudette J.V. Chan to Retire from the Board of Directors and Secretary, Effective June 19, 2025	CI
25-05-15	Tranche Update on FONAR Corporation's Equity Buyback Plan announced on September 29, 2022.	CI
25-05-15	FONAR Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2025	CI

Chart FONAR Corporation

Duration

Period

FONR: Dynamic Chart

Company Profile

FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.

Employees

535

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data